These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 1758464

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Severe gastrointestinal complications in patients with levodopa/carbidopa intestinal gel infusion.
    Klostermann F, Jugel C, Bömelburg M, Marzinzik F, Ebersbach G, Müller T.
    Mov Disord; 2012 Nov; 27(13):1704-5. PubMed ID: 23192929
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Parkinson disease treatment in hospitals and nursing facilities: avoiding pitfalls.
    Ahlskog JE.
    Mayo Clin Proc; 2014 Jul; 89(7):997-1003. PubMed ID: 24996235
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease.
    Hauser RA, Koller WC, Hubble JP, Malapira T, Busenbark K, Olanow CW.
    Mov Disord; 2000 May; 15(3):485-9. PubMed ID: 10830413
    [Abstract] [Full Text] [Related]

  • 28. Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease.
    Nyholm D, Nilsson Remahl AI, Dizdar N, Constantinescu R, Holmberg B, Jansson R, Aquilonius SM, Askmark H.
    Neurology; 2005 Jan 25; 64(2):216-23. PubMed ID: 15668416
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [The use of stalevo in the treatment of patients with Parkinson's disease].
    Kretova AS, Lyubimov AV.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014 Jan 25; 114(10):35-8. PubMed ID: 25591514
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Guillain-Barre/CIDP-like neuropathy in two parkinsonian patients following intestinal levodopa/carbidopa treatment.
    Galazky I, Schoof J, Stallforth S, Kupsch A, Heinze HJ, Kluge C.
    Parkinsonism Relat Disord; 2014 Jan 25; 20(1):125-7. PubMed ID: 24044946
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Adductor laryngeal breathing dystonia in a patient with lubag (X-linked dystonia-Parkinsonism syndrome).
    Lew MF, Shindo M, Moskowitz CB, Wilhelmsen KC, Fahn S, Waters CH.
    Mov Disord; 1994 May 25; 9(3):318-20. PubMed ID: 8041372
    [Abstract] [Full Text] [Related]

  • 39. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
    Prescrire Int; 2005 Apr 25; 14(76):51-4. PubMed ID: 15875340
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.